NVDA
52
-3
T
56
2
PEG
76
5
ADI
59
-2
BMY
56
3
DTE
63
7
TXT
58
-2
EMN
70
-2
RRC
56
4
SBUX
41
-3
ROK
44
-7
UAL
56
2
DE
53
8
C
60
-2
SIG
57
-3
HIG
68
4
PLD
51
-5
PGR
68
3
WBA
24
-3
FMC
40
4
NVDA
52
-3
T
56
2
PEG
76
5
ADI
59
-2
BMY
56
3
DTE
63
7
TXT
58
-2
EMN
70
-2
RRC
56
4
SBUX
41
-3
ROK
44
-7
UAL
56
2
DE
53
8
C
60
-2
SIG
57
-3
HIG
68
4
PLD
51
-5
PGR
68
3
WBA
24
-3
FMC
40
4
Financhill
Back

Krystal Biotech Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
31

KRYS
Krystal Biotech

Last Price:
184.28
Seasonality Move:
24.65%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
127.17
Seasonality Move:
0.19%
Sell
31
Krystal Biotech (KRYS) is a Sell

Is Krystal Biotech a Buy, Sell or Hold?

  • The current Krystal Biotech [KRYS] share price is $184.17. The Score for KRYS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • KRYS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $127.17. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KRYS Stock Price Chart

What is Krystal Biotech's stock price today?

  • The Krystal Biotech share price today is $184.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KRYS is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $127.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.

KRYS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.78 Sell
Relative Strength Index (14 RSI): 43.41 Sell
Chaikin Money Flow: -92826 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (186.5 - 199.98) Sell
Bollinger Bands (100): (166.39 - 199.21) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.52 Sell
Relative Strength Index (14 RSI): 38.9 Sell
Chaikin Money Flow: 50230 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (126.71 - 139.27) Sell
Bollinger Bands (100): (124.42 - 147.62) Sell

KRYS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 191.37 Sell
20-day SMA: 192.08 Sell
50-day SMA: 195.29 Sell
200-day SMA: 161.94 Buy
8-day EMA: 188.19 Sell
20-day EMA: 190.66 Sell
50-day EMA: 190.31 Sell
200-day EMA: 166.13 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.97 Buy
20-day SMA: 131.43 Sell
50-day SMA: 137.6 Sell
200-day SMA: 126.61 Buy
8-day EMA: 126.89 Buy
20-day EMA: 130.12 Sell
50-day EMA: 134.31 Sell
200-day EMA: 128.83 Sell

Krystal Biotech Earnings Growth & KRYS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.00 per share, an increase next quarter of $0.35 per share, an increase this year of $3.98 per share, and an increase next year of $1.95 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Krystal Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):